Award
National Heart, Lung, and Blood Institute 5R33HL166441-04
Intramuscular vs. Enteral Penicillin Prophylaxis to Prevent Progression of Latent Rheumatic Heart Disease: A non-inferiority randomized trial. (GOALIE)
Recipient
Cincinnati Children's Hospital Medical Center
Award Amount
$643,153.00
Ceiling
$643,153.00
Awarded
February 17, 2026
Identifier
5R33HL166441-04
NIH awarded a grant for a clinical trial comparing intramuscular and oral penicillin to prevent latent rheumatic heart disease, including screening and economic evaluation.
Description
This is a NIH grant for a clinical trial comparing intramuscular and oral penicillin for preventing latent rheumatic heart disease. The project involves echocardiographic screening of children, economic evaluation, and patient outcomes assessment.